Mankind Pharma Ltd (MANKIND) — Cash Flow Quality Index
Mankind Pharma Ltd (MANKIND) has a Cash Flow Quality Index of 1.72x as of September 2025. Operating cash flow of Rs16.37 Billion exceeds net income of Rs9.50 Billion, indicating high earnings quality where cash backs reported profits. Explore Mankind Pharma Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Mankind Pharma Ltd Cash Flow Quality Index (2019–2026)
Historical Cash Flow Quality Index for Mankind Pharma Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see MANKIND cash flow conversion.
Annual Cash Flow Quality Index for Mankind Pharma Ltd (2019–2026)
Year-by-year earnings quality comparison for Mankind Pharma Ltd.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 1.32x | Rs25.16 Billion | Rs19.13 Billion | ▲ +8.5% |
| 2025 | 1.21x | Rs24.13 Billion | Rs19.91 Billion | ▲ +7.7% |
| 2024 | 1.13x | Rs21.52 Billion | Rs19.13 Billion | ▼ -20.5% |
| 2023 | 1.41x | Rs18.13 Billion | Rs12.82 Billion | ▲ +203.7% |
| 2022 | 0.47x | Rs9.20 Billion | Rs19.75 Billion | ▼ -30.7% |
| 2021 | 0.67x | Rs11.37 Billion | Rs16.92 Billion | ▼ -9.6% |
| 2020 | 0.74x | Rs10.70 Billion | Rs14.38 Billion | ▼ -28.3% |
| 2019 | 1.04x | Rs6.00 Billion | Rs5.79 Billion | — |